• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫功能低下者肺炎的疫苗及其他预防策略

Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia.

作者信息

File Thomas M

机构信息

Infectious Disease Division, Summa Health, 75 Arch Street, Suite 506, Akron, OH 44304, USA; Infectious Disease Section, Northeast Ohio Medical University, Rootstown, OH, USA.

出版信息

Clin Chest Med. 2025 Mar;46(1):21-35. doi: 10.1016/j.ccm.2024.10.002. Epub 2024 Nov 29.

DOI:10.1016/j.ccm.2024.10.002
PMID:39890290
Abstract

Immunocompromised patients are more susceptible to infections. Although they have reduced immune response to vaccines, it is still essential to prioritize immunizations as one strategy to potentially reduce the impact of pneumonia in this vulnerable population. Response to immunizations in immunocompromised patients can be enhanced by increasing the dose of vaccines (eg, influenza) or by increasing the number of doses (eg, coronavirus disease 2019). Prophylactic use of antimicrobials, control of risk factors (avoidance of smoking), and stabilization of underlying conditions (eg, chronic obstructive pulmonary disease) can also have a beneficial effect to reduce the likelihood of pneumonia in the immunocompromised host.

摘要

免疫功能低下的患者更容易受到感染。尽管他们对疫苗的免疫反应有所降低,但将免疫接种作为一种潜在减轻这一脆弱人群肺炎影响的策略,仍然至关重要。通过增加疫苗剂量(如流感疫苗)或增加接种剂量次数(如2019冠状病毒病疫苗),可以增强免疫功能低下患者对免疫接种的反应。预防性使用抗菌药物、控制危险因素(避免吸烟)以及稳定基础疾病(如慢性阻塞性肺疾病),也有助于降低免疫功能低下宿主发生肺炎的可能性。

相似文献

1
Vaccines and Other Preventative Strategies for Immunocompromised Pneumonia.免疫功能低下者肺炎的疫苗及其他预防策略
Clin Chest Med. 2025 Mar;46(1):21-35. doi: 10.1016/j.ccm.2024.10.002. Epub 2024 Nov 29.
2
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses.针对不同免疫功能低下状况个体的新型冠状病毒mRNA疫苗纵向免疫原性队列研究:免疫反应的异质性及奥密克戎适应性加强剂量的关键作用
EBioMedicine. 2025 Mar;113:105577. doi: 10.1016/j.ebiom.2025.105577. Epub 2025 Feb 4.
3
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS).广泛免疫抑制人群中新型冠状病毒病 2019(COVID-19)疫苗反应的前瞻性评估:免疫抑制人群中的 COVID-19 疫苗接种研究(COVICS)。
Clin Infect Dis. 2022 Aug 24;75(1):e630-e644. doi: 10.1093/cid/ciac103.
4
The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future.免疫功能低下患者的 COVID-19 负担:对疫苗接种的影响和未来的需求。
J Infect Dis. 2023 Aug 4;228(Suppl 1):S4-S12. doi: 10.1093/infdis/jiad181.
5
Effectiveness of vaccination against SARS-CoV-2 and the need for alternative preventative approaches in immunocompromised individuals: a narrative review of systematic reviews.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗接种的有效性及免疫功能低下个体采用替代预防方法的必要性:系统评价的叙述性综述
Expert Rev Vaccines. 2023 Jan-Dec;22(1):341-365. doi: 10.1080/14760584.2023.2191716.
6
Uptake, effectiveness and safety of COVID-19 vaccines in individuals at clinical risk due to immunosuppressive drug therapy or transplantation procedures: a population-based cohort study in England.因免疫抑制药物治疗或移植手术而处于临床风险中的个体接种 COVID-19 疫苗的吸收率、效果和安全性:一项基于人群的英格兰队列研究。
BMC Med. 2024 Jun 10;22(1):237. doi: 10.1186/s12916-024-03457-1.
7
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial.为免疫功能低下人群优化 COVID-19 疫苗接种方案(BOOST-IC):一项适应性随机对照临床试验的研究方案。
Trials. 2024 Jul 17;25(1):485. doi: 10.1186/s13063-024-08315-2.
8
Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.肝移植受者和慢性肝病患者接种新冠疫苗后的抗体反应分析。
J Hepatol. 2021 Dec;75(6):1434-1439. doi: 10.1016/j.jhep.2021.08.008. Epub 2021 Aug 26.
9
Cowpox to COVID: History of vaccination in the immunocompromised host.牛痘到新冠:免疫功能低下宿主的疫苗接种史。
Transpl Infect Dis. 2023 Jun;25(3):e14051. doi: 10.1111/tid.14051. Epub 2023 Apr 7.
10
Protracted course of SARS-CoV-2 pneumonia in moderately to severely immunocompromised patients.中度至重度免疫功能低下患者的 SARS-CoV-2 肺炎迁延不愈。
Clin Exp Med. 2023 Oct;23(6):2255-2264. doi: 10.1007/s10238-022-00984-0. Epub 2023 Jan 6.